Leading Headache Specialists
Are you an adult who suffer from migraine? We invite you to see if you qualify for one of our migraine research studies and help uncover better treatments for millions affected by this condition worldwide.
Adult Migraine Studies
Prevention Studies
We’re currently enrolling adults 18 and older in four clinical trials for migraine prevention. If you experience:
-
Episodic migraines (at least 1 migraine per month), or
-
Chronic migraines (15 or more headache days per month),
you may qualify to participate.
These studies are testing medications from a group known as botulinum toxins — treatments that work similarly to Botox for migraine relief.
We’re currently studying two FDA-approved medications: Dysport and Xeomin, both already FDA-approved for other medical and cosmetic uses.
Each study includes 4 treatment sessions, one every 12 weeks, using small injections in the head and neck, just like standard Botox migraine therapy.
All our studies are registered with ClinicalTrials.gov, a reliable source for clinical research information.
-
Xeomin for Episodic Migraine – Coming Soon
-
Xeomin for Chronic Migraine – Coming Soon